Which of the following medications is indicated to treat hyperkalemia?

Rationale

Lokelma is indicated to treat hyperkalemia.

Lokelma, known generically as sodium zirconium cyclosilicate, is specifically designed to lower elevated potassium levels in the blood, making it a targeted treatment for hyperkalemia.

A (Levoxyl) YOUR ANSWER

Levoxyl is a brand name for levothyroxine, a synthetic form of the thyroid hormone used primarily to treat hypothyroidism. It does not have any indication or effect on potassium levels, and therefore is not used for hyperkalemia.

B (Loperamide) YOUR ANSWER

Loperamide is an anti-diarrheal medication that works by slowing down gut movement. It is not related to potassium management and has no role in treating hyperkalemia, as it does not affect serum potassium levels.

C (Levetiracetam) YOUR ANSWER

Levetiracetam is an anticonvulsant used to treat seizures in epilepsy. While it has various neurological applications, it does not play any role in managing potassium levels in the body and is not indicated for hyperkalemia treatment.

D (Lokelma) CORRECT

Lokelma is a medication specifically indicated for the treatment of hyperkalemia. It works by binding potassium in the gastrointestinal tract, promoting its excretion and effectively lowering serum potassium levels.

Conclusion

Treating hyperkalemia requires medications that specifically target elevated potassium levels in the blood. Lokelma is the only option listed that is indicated for this purpose, while the other choices serve entirely different therapeutic roles unrelated to potassium management. Understanding the specific indications of medications is crucial for effective treatment of conditions like hyperkalemia, ensuring patient safety and health.

Which of the following medications is indicated to treat hyperkalemia?

Lokelma is indicated to treat hyperkalemia.

Related Questions

Related Quizzes

How familiar were you with this question?

Report an Issue

Rate this Practice Test